Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EYA3 | Q99504 | 3/20 | 0.67 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.67 |
| ▸ | TTR | P02766 | 1/20 | 0.62 |
| ▸ | KDM5A | P29375 | 3/20 | 0.52 |
| ▸ | THRA | P10827 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.52 |
| ▸ | KDM7A | Q6ZMT4 | 2/20 | 0.52 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.52 |
| ▸ | SIRT3 | Q9NTG7 | 6/20 | 0.52 |
| ▸ | KDM4A | O75164 | 2/20 | 0.52 |
| ▸ | ING2 | Q9H160 | 1/20 | 0.52 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18743965 | 0.85 | EYA3 (0.58) | EYA3PTPN1TTRKDM5ATHRA | |
| SCHEMBL11851343 | 0.84 | EYA3 (0.72) | EYA3PTPN1TTRKDM5ATHRA | |
| SCHEMBL3223737 | 0.84 | EYA3 (0.81) | EYA3PTPN1TTRKDM5ATHRA | |
| SCHEMBL11844336 | 0.84 | TTR (0.79) | EYA3PTPN1TTRKDM5ATHRA | |
| SCHEMBL18743963 | 0.82 | KDM7A (0.65) | EYA3TTRKDM5ATHRATHRB | |
| SCHEMBL15313191 | 0.82 | EYA3 (0.60) | EYA3PTPN1TTRKDM5ATHRA | |
| SCHEMBL11844885 | 0.82 | EYA3 (0.68) | EYA3PTPN1TTRKDM5ATHRA | |
| SCHEMBL9195719 | 0.81 | EYA3 (0.73) | EYA3PTPN1TTRKDM5ATHRA | |
| SCHEMBL1287970 | 0.81 | EYA3 (1.00) | EYA3PTPN1TTRKDM5ATHRA | |
| SCHEMBL15313186 | 0.80 | SIRT3 (0.66) | EYA3PTPN1TTRKDM5ATHRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9895340-B2 | Fluorinated benzofuran derivatives | SCIFLUOR LIFE SCIENCES, INC. (US) | 2018-02-20 | — | — | US | disclosed |
| US-9895340-B2 | Fluorinated benzofuran derivatives | SCIFLUOR LIFE SCIENCES, INC. (US) | 2018-02-20 | — | — | US | disclosed |
| US-20170189370-A1 | FLUORINATED BENZOFURAN DERIVATIVES | FELIQS CORPORATION (JP) | 2017-07-06 | — | — | US | disclosed |
| US-20170189370-A1 | FLUORINATED BENZOFURAN DERIVATIVES | FELIQS CORPORATION (JP) | 2017-07-06 | — | — | US | disclosed |
| US-20170189370-A1 | FLUORINATED BENZOFURAN DERIVATIVES | FELIQS CORPORATION (JP) | 2017-07-06 | — | — | US | disclosed |
| EP-2838890-B1 | FLUORINATED BENZOFURAN DERIVATIVES | SCIFLUOR LIFE SCIENCES INC (US) | 2017-06-21 | — | — | EP | disclosed |
| EP-2838890-B1 | FLUORINATED BENZOFURAN DERIVATIVES | SCIFLUOR LIFE SCIENCES INC (US) | 2017-06-21 | — | — | EP | disclosed |
| US-9624189-B2 | Fluorinated benzofuran derivatives | SCIFLUOR LIFE SCIENCES, INC. (US) | 2017-04-18 | — | — | US | disclosed |
| US-9624189-B2 | Fluorinated benzofuran derivatives | SCIFLUOR LIFE SCIENCES, INC. (US) | 2017-04-18 | — | — | US | disclosed |
| US-9624189-B2 | Fluorinated benzofuran derivatives | SCIFLUOR LIFE SCIENCES, INC. (US) | 2017-04-18 | — | — | US | disclosed |
| EP-2838890-A1 | FLUORINATED BENZOFURAN DERIVATIVES | Scifluor Life Sciences, LLC (US) | 2015-02-25 | — | — | EP | disclosed |
| WO-2013158251-A1 | FLUORINATED BENZOFURAN DERIVATIVES | SCIFLUOR LIFE SCIENCES, LLC (US) | 2013-10-24 | — | — | WO | disclosed |
| US-20130274325-A1 | Fluorinated Benzofuran Derivatives | FELIQS CORPORATION (JP) | 2013-10-17 | — | — | US | disclosed |
| US-20130274325-A1 | Fluorinated Benzofuran Derivatives | FELIQS CORPORATION (JP) | 2013-10-17 | — | — | US | disclosed |
| US-20130274325-A1 | Fluorinated Benzofuran Derivatives | FELIQS CORPORATION (JP) | 2013-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130274325-A1 | Fluorinated Benzofuran Derivatives | FABP3, TNNI3, TNNT2 | EYA3 3283/4885PTPN1 4361/4885TTR 1341/4885 |
| US-20170189370-A1 | FLUORINATED BENZOFURAN DERIVATIVES | FABP3, TNNI3, TNNT2 | EYA3 3283/4885PTPN1 4361/4885TTR 1341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.